Partnership for Research on Ebola Vaccines in Liberia (PREVAIL)

NCT02344407 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1500

Enrollment

NIH

Sponsor class

Conditions

Ebola Virus

Interventions

BIOLOGICAL: VSVG-ZEBOV
BIOLOGICAL: ChAd3-EBO Z
BIOLOGICAL: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)